
Theratechnologies THTX
Annual report 2024
added 04-25-2026
Theratechnologies Operating Cycle 2011-2026 | THTX
Annual Operating Cycle Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 456 | 738 | 1.21 K | 1.71 K | 1.07 K | - | 92.2 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 92.2 K | 456 | 16.2 K |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.88 | -1.69 % | $ 6.47 M | ||
|
Aquestive Therapeutics
AQST
|
223 | $ 4.1 | 1.23 % | $ 438 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
332 | $ 22.45 | 1.13 % | $ 3.72 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
Berkeley Lights
BLI
|
349 | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | ||
|
Cerus Corporation
CERS
|
47 | $ 2.03 | 5.73 % | $ 387 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Caladrius Biosciences
CLBS
|
164 | - | -16.75 % | $ 25.8 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.1 K | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Dynavax Technologies Corporation
DVAX
|
512 | - | - | $ 2.02 B | ||
|
Editas Medicine
EDIT
|
142 | $ 3.0 | 6.38 % | $ 266 M | ||
|
Edesa Biotech
EDSA
|
97.1 | $ 18.27 | 14.94 % | $ 58.4 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
33.6 K | - | -9.21 % | $ 2.55 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M |